Add like
Add dislike
Add to saved papers

Supercritical CO2 and ionic liquids for the pretreatment of lignocellulosic biomass in bioethanol production.

Owing to high petroleum prices, there has been a major push in recent years to use lignocellulosic biomass as biorefinery feedstocks. Unfortunately, by nature's design, lignocellulosic biomass is notoriously recalcitrant. Cellulose is the most abundant renewable carbon source on the planet and comprises glucan polysaccharides which self-assemble into paracrystalline microfibrils. The extent of cellulose crystallinity largely contributes to biomass recalcitrance. Additionally, cellulose microfibrils are embedded into both hemicellulose and lignin polymeric networks, making cellulose accessibility an additional obstacle. Pretreatment is necessary before enzymatic hydrolysis in order to liberate high yields of glucose and other fermentable sugars from biomass polysaccharides. This work discusses two pretreatment methods, supercritical CO2 and ionic liquids (ILs). Both methods utilize green solvents that do not emit toxic vapours. Mechanisms for destroying or weakening biomass recalcitrance have been explored. Various pretreatment operating parameters such as temperature, pressure, time, dry biomass/solvent ratio, water content, etc. have been investigated for the pretreatment of various biomass types such as corn stover, switchgrass, sugarcane bagasse, soft and hard wood. The two pretreatment methods have their pros and cons. For example, supercritical CO2 explosion pretreatment uses inexpensive CO2, but requires a high pressure. By comparison, while IL pretreatment does not require an elevated pressure, ILs are still too expensive for large-scale uses. Further research and development are needed to make the two green pretreatment methods practical.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app